Literature DB >> 1993663

Kinetics of dissociation of the tubulin-colchicine complex. Complete reaction scheme and comparison to thermodynamic measurements.

J Fernando Díaz1, J M Andreu.   

Abstract

The slow dissociation reaction of the tubulin-colchicine complex has been characterized in purified calf brain tubulin and microtubule protein preparations, using [3H]colchicine and fluorometric measurements. It fits to a single exponential phase, within the accuracy of these measurements. The dissociation is a kinetically unfavorable reaction, with activation energy values of 114 +/- 10 and 94 +/- 10 kJ mol-1 (purified tubulin and microtubule protein, respectively). The kinetic scheme previously proposed for the tubulin-colchicine association (Lambeir, A., and Engelborghs, Y. (1981) J. Biol. Chem. 256, 3279-3282) is: T + C K1 in equilibrium TC k2 in equilibrium k-2 (TC)' where step 1 is a fast reversible binding and step 2 is a slow conformational change, whose backward rate constant (k-2) was neglected for the association study. This kinetic scheme has now been completed to include the measurements of the rate-limiting dissociation step (k-2), and of the purified calf brain tubulin preparation. The overall binding standard free energy change, calculated from the kinetic measurements, is -42.0 +/- 0.1 kJ mol-1 (fast phase of binding in 10 mM sodium phosphate buffer, 0.1 mM GTP, pH 7.0, at 37 degrees C). The binding is exothermic and the calculated enthalpy change is -26 +/- 13 kJ mol-1, which coincides with the recently determined calorimetric enthalpy value, -21 +/- 2 kJ mol-1 (Menendez, M., Laynez, J., Medrano, F. J., and Andreu, J. M. (1989) J. Biol. Chem. 264, 16367-16371), suggesting that the kinetic scheme and measurements are essentially correct.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1993663

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Mechanism of tubulin-colchicine recognition: a kinetic study of the binding of the colchicine analogues colchicide and isocolchicine.

Authors:  C Dumortier; Q Yan; S Bane; Y Engelborghs
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

2.  Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules.

Authors:  A Vandecandelaere; S R Martin; Y Engelborghs
Journal:  Biochem J       Date:  1997-04-01       Impact factor: 3.857

3.  Screening Anti-Cancer Drugs against Tubulin using Catch-and-Release Electrospray Ionization Mass Spectrometry.

Authors:  Reza Rezaei Darestani; Philip Winter; Elena N Kitova; Jack A Tuszynski; John S Klassen
Journal:  J Am Soc Mass Spectrom       Date:  2016-03-04       Impact factor: 3.109

4.  P-glycoprotein inhibition leads to enhanced disruptive effects by anti-microtubule cytostatics at the in vitro blood-brain barrier.

Authors:  I C van der Sandt; P J Gaillard; H H Voorwinden; A G de Boer; D D Breimer
Journal:  Pharm Res       Date:  2001-05       Impact factor: 4.200

5.  Gatorbulin-1, a distinct cyclodepsipeptide chemotype, targets a seventh tubulin pharmacological site.

Authors:  Susan Matthew; Qi-Yin Chen; Ranjala Ratnayake; Charles S Fermaintt; Daniel Lucena-Agell; Francesca Bonato; Andrea E Prota; Seok Ting Lim; Xiaomeng Wang; J Fernando Díaz; April L Risinger; Valerie J Paul; Maria Ángela Oliva; Hendrik Luesch
Journal:  Proc Natl Acad Sci U S A       Date:  2021-03-02       Impact factor: 11.205

6.  P-glycoprotein is more efficient at limiting uptake than inducing efflux of colchicine and vinblastine in HL-60 cells.

Authors:  X Declèves; O Chappey; B Boval; E Niel; J M Scherrmann
Journal:  Pharm Res       Date:  1998-05       Impact factor: 4.200

7.  High-affinity ligands of the colchicine domain in tubulin based on a structure-guided design.

Authors:  Oskía Bueno; Juan Estévez Gallego; Solange Martins; Andrea E Prota; Federico Gago; Asier Gómez-SanJuan; María-José Camarasa; Isabel Barasoain; Michel O Steinmetz; J Fernando Díaz; María-Jesús Pérez-Pérez; Sandra Liekens; Eva-María Priego
Journal:  Sci Rep       Date:  2018-03-09       Impact factor: 4.379

8.  Identification of pyrrolopyrimidine derivative PP-13 as a novel microtubule-destabilizing agent with promising anticancer properties.

Authors:  Pauline Gilson; Fernando Josa-Prado; Claire Beauvineau; Delphine Naud-Martin; Laetitia Vanwonterghem; Florence Mahuteau-Betzer; Alexis Moreno; Pierre Falson; Laurence Lafanechère; Véronique Frachet; Jean-Luc Coll; Jose Fernando Díaz; Amandine Hurbin; Benoit Busser
Journal:  Sci Rep       Date:  2017-08-31       Impact factor: 4.379

9.  N-alkylisatin-based microtubule destabilizers bind to the colchicine site on tubulin and retain efficacy in drug resistant acute lymphoblastic leukemia cell lines with less in vitro neurotoxicity.

Authors:  Bryce Keenan; Rocio K Finol-Urdaneta; Ashleigh Hope; John B Bremner; Maria Kavallaris; Daniel Lucena-Agell; María Ángela Oliva; Jose Fernando Díaz; Kara L Vine
Journal:  Cancer Cell Int       Date:  2020-05-15       Impact factor: 5.722

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.